Victoria Kong

Ms. Victoria Kong

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2026 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
MKMartin Kauke-Navarro
Martin Kauke-Navarro
ARAlbert L. Rancu
Albert L. Rancu
MMMoritz Milewski
Moritz Milewski
VKVictoria Kong
Victoria Kong
OAOmar Allam
Omar Allam
MAMichael Alperovich
Michael Alperovich
Opioid stewardship has changed surgical prescribing yet discharge opioid use after cleft lip and palate repair remains poorly described. No prior study has tied the prescribing habits to postoperative complications. Using the 2023 to 2024 NSQIP-Pediatric files, we identified primary cleft lip and palatoplasty cases and characterized the prevalence, predictors, and 30-day safety of discharge opioid prescribing after primary cleft repair. Predictors of discharge opioid receipt were assessed with multivariable logistic regression. For each 30-day complication, the association with prescribing was estimated 3 ways: covariate-adjusted regression, propensity-score matching, and inverse-probability weighting, with correction for multiple comparisons. Among 7758 children (3431 cleft lip; 4327 palatoplasty), 43.8% and 51.7% received a discharge opioid, respectively. Higher ASA class and longer operative time increased the odds of opioid prescribing. Black children undergoing palatoplasty had lower adjusted odds than White children (OR 0.59, P <0.001). No complication differed by opioid status after correction. Wound dehiscence and reoperation, the outcomes most tied to protecting the repair, were nearly identical between prescribed and nonprescribed children. Discharge opioid prescribing after primary cleft repair varied widely by surgeon specialty and by race but was not associated with 30-day complications, readmission, or reoperation. Because lower prescribing was not accompanied by higher rates of dehiscence, reoperation, or readmission, opioid-sparing discharge protocols are unlikely to compromise surgical outcomes and offer a route toward more consistent and equitable prescribing.

25 August 2026 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
ASAndrew Salib
Andrew Salib
SGSamira Glaeser-Khan
Samira Glaeser-Khan
VKVictoria Kong
Victoria Kong
JMJake Moscarelli
Jake Moscarelli
MAMichael Alperovich
Michael Alperovich
Background: This study examines temporal trends in otoplasty volume and inflation-adjusted cost, and characterizes variation by patient age, sex, anesthesia type, insurance, and geographic region using a national pediatric hospital database. Methods: Retrospective cohort analysis of the Pediatric Health Information System (PHIS) database. Patients undergoing otoplasty (CPT 69300) from 2000 to 2025 were identified. Patients with congenital ear malformations other than a prominent ear (ICD-10 Q17.5) were excluded. Annual procedure volume and inflation-adjusted estimated costs were modeled with ordinary least-squares regression. Differences in cost across anesthesia type, insurance category, and census region were assessed with Kruskal-Wallis and Wilcoxon pairwise tests. Results: A total of 3428 patients underwent otoplasty (51.7% male). Annual volume increased significantly (β=3.7 procedures/year, R 2 =0.57, P <0.001). Inflation-adjusted median cost rose by $161/year ( R 2 =0.67, P <0.001). Median age at surgery was 8.0 years (IQR: 6–12). General anesthesia was associated with higher costs than local anesthesia ($6930 versus $5355; P <0.001). Costs were highest in the West ($7136) and lowest in the South ($4793; P <0.001). Medicaid/CHIP patients incurred higher median costs than privately insured patients ($7188 versus $6496; P =0.010). Conclusions: Otoplasty utilization and real costs have increased significantly at U.S. children’s hospitals over the past 2 decades. Meaningful variation exists by anesthesia type, payer, and geography. These findings highlight opportunities to standardize care delivery and address cost disparities in pediatric otoplasty.

31 July 2026 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
JMJake Moscarelli
Jake Moscarelli
ASAndrew Salib
Andrew Salib
JSJulian Smith-Voudouris
Julian Smith-Voudouris
VKVictoria Kong
Victoria Kong
OAOmar Allam
Omar Allam
MAMichael Alperovich
Michael Alperovich
Background: Although current guidelines discourage extended antibiotic prophylaxis, it remains commonly used in the clinical practice of mandible fractures. The current study evaluated associations between extended preoperative or postoperative antibiotic prophylaxis, and 90-day adverse events after open reduction and internal fixation (ORIF) of closed mandible fractures. Methods: Patients undergoing ORIF for closed mandible fractures were identified from a large, national, administrative database and stratified by antibiotic exposure: extended preoperative prophylaxis (defined as antibiotic exposure the same day as fracture to one day before ORIF), extended postoperative prophylaxis (within 1 wk after ORIF), or no documented extended antibiotics beyond standard perioperative care. Exclusion criteria included long bone fractures, age under 18, history of dental caries or implants, fewer than 90 days of follow-up, and early postoperative infectious diagnoses that would indicate antibiotics were given for treatment rather than prophylaxis. Primary outcomes included 90-day surgical site infections, osteomyelitis, face abscess, wound debridement, nonunion, malocclusion, wound dehiscence, hardware removal, and overall complications. Multivariable logistic regression controlled for patient demographics and comorbidities. Results: Of 16,110 patients identified, extended preoperative antibiotics were used for 9.4%, extended postoperative antibiotics were used for 26.2% of patients, and no extended prophylaxis was used for 64.4%. Although debridement rates were slightly lower in the postoperative antibiotic group versus no prophylaxis (0.5% versus 1.1%; P =0.003), neither preoperative nor postoperative antibiotics were associated with any other reduced postoperative complications on univariable or multivariable analyses. Conclusions: Extended outpatient antibiotic prophylaxis was not associated with improved outcomes after ORIF of closed mandible fractures. These findings call this practice into question.

17 August 2026 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
VKVictoria Kong
Victoria Kong
ASAndrew Salib
Andrew Salib
OAOmar Allam
Omar Allam
KBKaren Bach
Karen Bach
SGSamira Glaeser-Khan
Samira Glaeser-Khan
MAMichael Alperovich
Michael Alperovich
Background: Simultaneous primary cheilorhinoplasty offers early aesthetic and functional benefits, yet the longitudinal childhood surgical burden across cleft phenotype remains poorly defined. This study compared the timing, frequency, and likelihood of childhood secondary nasal intervention following primary simultaneous cheilorhinoplasty. Methods: A multicenter retrospective study using the Pediatric Health Information System (2004–2025) identified patients 16 years of age or younger who underwent primary cheilorhinoplasty at less than 12 months of age. Patients were stratified by cleft phenotype [unilateral cleft lip (UCL), bilateral cleft lip (BCL), unilateral cleft lip and palate (UCLP), and bilateral cleft lip and palate (BCLP)]. Negative binomial regression, Cox proportional hazards modeling, and multivariable logistic regression evaluated the rate, timing, and probability of secondary nasal intervention before age 16. Results: Of 1291 patients (median follow-up: 8.3 y), secondary intervention rates were significantly higher for UCLP (aIRR: 2.86) and BCLP (aIRR: 3.73) relative to UCL (all P <0.001). BCLP exhibited a 31% higher rate than UCLP (ratio: 1.31; 95% CI: 1.00–1.71; P =0.017). Cox modeling confirmed the earlier revision (UCLP aHR: 3.04; BCLP aHR: 3.70; both P <0.001). Adjusted 15-year cumulative incidence of secondary nasal intervention was 16.5% (UCL), 42.3% (UCLP), and 48.8% (BCLP). UCLP was independently associated with deviated septum (aOR: 3.87; p FDR =0.015) and BCLP with obstructive sleep apnea (aOR: 2.64; p FDR =0.025). Median age at the second nasal procedure was 5.4 years. Conclusions: Cleft phenotype severity is independently associated with secondary nasal surgical burden. Greater phenotypic severity is linked to earlier, more frequent, and more probable nasal surgery, with burden highest in BCLP, followed by UCLP, relative to UCL.